Abstract
Secondary metabolites are a reliable and very important source of medicinal compounds. While these molecules have been mined extensively, genome sequencing has suggested that there is a great deal of chemical diversity and bioactivity that remains to be discovered and characterized. A central challenge to the field is that many of the novel or poorly understood molecules are expressed at low levels in the laboratory-such molecules are often described as the 'cryptic' secondary metabolites. In this review, we will discuss evidence that research in this field has provided us with sufficient knowledge and tools to express and purify any secondary metabolite of interest. We will describe 'unselective' strategies that bring about global changes in secondary metabolite output as well as 'selective' strategies where a specific biosynthetic gene cluster of interest is manipulated to enhance the yield of a single product. © 2013 Japan Antibiotics Research Association. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Craney, A., Ahmed, S., & Nodwell, J. (2013, July). Towards a new science of secondary metabolism. Journal of Antibiotics. https://doi.org/10.1038/ja.2013.25
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.